NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice-Reference-Cited by-同舟云学术

NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice

Published:2018-05-18 Issue:35 Volume:37 Page:4854-4870
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Gabbasov Rashid,Xiao Fang,Howe Caitlin G.,Bickel Laura E.,O’Brien Shane W.,Benrubi Daniel,Do Thuy-Vy,Zhou Yan,Nicolas Emmanuelle,Cai Kathy Q.,Litwin Samuel,Seo Sachiko,Golemis Erica A.^ORCID,Connolly Denise C.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-018-0296-y.pdf

Reference56 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: A Cancer J Clin. 2016;66:7–30.

2. Bowtell DD, Bohm S, Ahmed AA, Aspuria PJ, Bast RC Jr., Beral V, et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015;15:668–79.

3. McPherson A, Roth A, Laks E, Masud T, Bashashati A, Zhang AW, et al. Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer. Nat Genet. 2016;48:758–67.

4. TCGA. Integrated genomic analyses of ovarian carcinoma. Nature . 2011;474:609–15.

5. Bonome T, Levine DA, Shih J, Randonovich M, Pise-Masison CA, Bogomolniy F, et al. A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer Res. 2008;68:5478–86.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcription factor 7 like 2 promotes metastasis in hepatocellular carcinoma via NEDD9-mediated activation of AKT/mTOR signaling pathway;Molecular Medicine;2024-07-25

2. Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction–associated steatohepatitis;Hepatology Communications;2024-04-12

3. Reciprocal Relationship Between Cancer Stem Cells and Myeloid-Derived Suppressor Cells: Implications for Tumor Progression and Therapeutic Strategies;Future Oncology;2024-02

4. Treatment of rheumatoid arthritis with baricitinib or upadacitinib is associated with reduced scaffold protein NEDD9 levels in CD4+ T cells;Physiological Reports;2023-09-28

5. NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer;Cancers;2023-02-09